1288782723
RealTalk MS

Advertise on podcast: RealTalk MS

Rating
★★★★★
4.7
from
153 reviews
This podcast has
535 episodes
Language
English
Publisher
Jon Strum
Explicit
No
Date created
2017/09/22
Latest episode
2026/11/09
Average duration
35 min.
Release period
7 days

Description

Jon Strum cuts through all the jargon and breaks down the latest multiple sclerosis news. You'll meet the scientists who are creating tomorrow's MS treatments today. You'll hear from the experts discussing how the latest tweaks and changes to our healthcare laws will impact your MS treatment. And we'll be talking to the courageous MS warriors who are out there advocating on behalf of the MS community every day, as well as the men and women who are committed to living their best lives with MS and living their best lives as MS caregivers. If you're dealing with multiple sclerosis in your life -- as a patient, caregiver, family member, or friend -- join us each week for RealTalk MS.

Unlock RealTalk MS podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from RealTalk MS podcast


It's Time to Update the Way We Describe MS with Dr. Peter Calabresi
2026/11/09
The current clinical language used to describe multiple sclerosis hasn't kept pace with modern neuroscience—and clinging to outdated categories can stall treatment decisions, muddy research, and obscure what people living with MS actually experience. This week, we're exploring why it's time to modernize how we define and discuss the disease course, grounded in underlying biology rather than superficial clinical labels.   Joining the conversation is Dr. Peter Calabresi, who chaired the pivotal session "Biological Disease Course Descriptors" at MS Toronto 2026, to break down the latest consensus, what biological descriptors mean for day-to-day clinical care, and how updating our vocabulary will accelerate smarter, more personalized therapeutic strategies. We're also reporting encouraging clinical trial results for people living with non-active secondary progressive MS. And we're sharing a very sad story that should remind all of us that AI chatbots like ChatGPT shouldn't be practicing medicine. We have a lot to talk about. Are you ready for RealTalk MS??! This Week:  Why it's time to update the way we describe MS  :22 Encouraging Phase 2a clinical trial results for people with non-active secondary progressive MS 7:56 A cautionary tale illustrates why AI chatbots shouldn't practice medicine   14:40 Dr. Peter Calabresi explains the why and how of adopting biologically-driven MS course descriptors  19:33 Share this episode  28:54 Have you downloaded the RealTalk MS app?  29:14 Next week  30:00 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/481 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com DOWNLOAD: The RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share READ: Patient Voice: The Label Given to My MS Disease Course Matters To Me: YES! https://journals.sagepub.com/doi/10.1177/13524585251396262 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 481 Guests: Dr. Peter Calabresi Privacy Policy
MSToronto 2026 with Dr. Jeffrey Cohen and Dr. Robert Fox
2026/11/02
Our coverage of MSToronto 2026 continues this week with two important conversations. First, we'll hear from Dr. Jeffrey Cohen about the latest clinical findings on CAR-T cell therapy as a potential treatment for MS. Then, Dr. Robert Fox will update us on the global research portfolio being driven by the International Progressive MS Alliance.   And we have to talk about Christina Applegate. By now, the news of her misdiagnosis isn't really news. But we have some suggestions for how you might want to process that news. We have a lot to talk about. Are you ready for RealTalk MS??! This Week:  MSToronto 2026  :22 But, first, we have to talk about Christina Applegate  :46 Dr. Jeffrey Cohen discusses what the experts are learning about  CAR-T cell therapy   6:51 Dr. Robert Fox shares an update on the global work being driven by the International Progressive MS Alliance  19:03 Share this episode  34:21 Have you downloaded the RealTalk MS app?  34:40 Next week  35:25 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/480 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com DOWNLOAD: The RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share PARTICIPATE: Phase 3 Clinical Trial for Orelabrutinib and Non-Active Secondary Progressive MS https://clinicaltrials.gov/study/NCT07299019 PARTICIPATE: Phase 3 Clinical Trial for Orelabrutinib and Primary Progressive MS https://clinicaltrials.gov/study/NCT07067463 LISTEN: RealTalk MS Episode 424: I'm a Participant in a Clinical Trial for CAR T-Cell Therapy and MS with Jan Janisch-Hanzlik https://realtalkms.com/424 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 480 Guests: Dr. Jeffrey Cohen and Dr. Robert Fox Privacy Policy
Episode 479: From MSToronto 2026 with Dr. Bruce Bebo and Kristine Werner Ozug
2026/10/29
Last week, about 8,000 MS researchers and clinicians arrived in Toronto, Canada, for MSToronto 2026, the joint meeting of the Americas Committee for Treatment and Research in MS and the European Committee for Treatment and Research in MS, and the largest MS research conference in the world.    As the meeting adjourned, the National MS Society's Chief Research and Medical Affairs Officer, Dr. Bruce Bebo, joined me to share some of the presentations and announcements that he found particularly important. My RealTalk MS teammate, Kristine Werner Ozug, also joined me in Toronto. Drawing on her own journey with MS, Kristine brings invaluable personal insight to the table. This week, Kristine shares the research and critical conversations that she's taking away from MS Toronto 2026. We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  MSToronto 2026  :22 Dr. Bruce Bebo shares the presentations and announcements that he found particularly important at MS Toronto 2026  1:11 Kristine Werner Ozug shares her take-aways from MS Toronto 2026  13:54 Share this episode  43:37 Have you downloaded the RealTalk MS app?  43:57 Next Week: More from MS Toronto 2026!  44:43 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/479 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com DOWNLOAD: The RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share WATCH: National MS Society Webinar -- MS Advocacy in Action: What the 2026 Elections Could Mean for Healthcare Policy and Access to Care https://youtube.com/watch?v=7AHyGKuRxvw VISIT: The Congressional Health Care Access Report Card https:/realtalkms.com/congressional-healthcare-access-report-card/ JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 479 Guest: Dr. Bruce Bebo and Kristine Werner Ozug Privacy Policy
Episode 478: From MSToronto 2026 Patient Community Day with Professor Peter Feys and Karen Jacoby
2026/10/26
Welcome to a special episode of RealTalk MS and The ECTRIMS Podcast! MS Toronto 2026 concluded with the event we were most looking forward to -- Patient Community Day -- where some of the top MS experts in the world broke down the research presented over the course of the 3-day meeting and answered questions from people living with MS in easy-to-understand English.     In this special episode, Professor Peter Feys, an MS rehabilitation expert from Hasselt University in Belgium, and Karen Jacoby, who lives with MS and serves as an MSCanada Ambassador, stepped off the stage at Patient Community Day to share their perspectives on MSToronto 2026. We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  MSToronto 2026 Patient Community Day  :25 Just after stepping off stage at Patient Community Day, Professor Peter Feys and Karen Jacoby share their thoughts on MSToronto 2026  1:21 Share this episode  19:57 Have you downloaded the RealTalk MS app?  20:17 Don't miss Thursday's Special Episode!  20:59 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/478 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com DOWNLOAD: The RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share WATCH: National MS Society Webinar -- MS Advocacy in Action: What the 2026 Elections Could Mean for Healthcare Policy and Access to Care https://youtube.com/watch?v=7AHyGKuRxvw VISIT: The Congressional Health Care Access Report Card https:/realtalkms.com/congressional-healthcare-access-report-card/ JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 478 Guest: Professor Peter Feys and Karen Jacoby Privacy Policy
Episode 477: One Year After CAR T-Cell Therapy with Jan Janisch-Hanzlik
2026/10/19
Jan Janisch-Hanzlik was the first MS patient to receive CAR T-cell therapy as part of a clinical trial. We met Jan last year, in episode 424 of RealTalk MS, when she gave us a first-hand report on how she was responding to this treatment.    This week, Jan is back with an update on how she's responding to CAR T-cell therapy one year later. We're just two weeks away from the U.S. midterm elections. We're sharing some resources that will help you get ready to vote. And we'll remind you that MSToronto 2026 begins tomorrow, and you still have time to register for Patient Community Day. We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  An update one year after receiving CAR T-cell therapy  :22 Some homework to help get you ready to vote in the U.S. midterm elections   2:44 Jan Janisch-Hanzlik shares an update one year after receiving CAR T-cell therapy to treat her MS   6:37 Share this episode  28:11 Have you downloaded the RealTalk MS app?  28:31 Next week  29:12 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/477 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com DOWNLOAD: The RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share REGISTER: ECTRIMS Patient Community Day 2026 https://ectrimspatientcommunity.eu WATCH: National MS Society Webinar -- MS Advocacy in Action: What the 2026 Elections Could Mean for Healthcare Policy and Access to Care https://youtube.com/watch?v=7AHyGKuRxvw VISIT: The Congressional Health Care Access Report Card https:/realtalkms.com/congressional-healthcare-access-report-card/ LISTEN: RealTalk MS Episode 424: I'm a Participant in a Clinical Trial for CAR T-Cell Therapy and MS with Jan Janisch-Hanzlik https://realtalkms.com/424 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 477 Guest: Jan Janisch-Hanzlik Privacy Policy
MS in the Workplace with Dana Foote
2026/10/12
What happens when you're diagnosed with a chronic, unpredictable condition just as your career is taking off? That's exactly what happened to my guest, Dana Foote.   This week, Dana joins us to share her journey from hiding her MS diagnosis as a young auditor at one of the largest accounting organizations in the world to becoming National Managing Partner for Audit & Assurance Operations and a leader in the MS community. We'll also update you on the status of a disease-modifying therapy that has been submitted to the FDA for review as a potential treatment for relapsing MS and primary progressive MS. We're sharing details of the National MS Society's recent $8.9 million investment to support 15 cutting-edge research projects. We'll tell you about a study that shows physical therapy can produce confirmed disability improvement for people living with MS. And we'll remind you that with MSToronto 2026 just one week away, you can still register for Patient Community Day. We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  Managing MS in a demanding, high-stakes work environment  :22 The FDA grants fenebrutinib Priority Review status   1:22 The National MS Society announced $8.9 million in new research investments   4:53 A study shows ongoing physical therapy can lead to confirmed disability improvement   9:12 We're one week away from MSToronto 2026. Will you be part of Patient Community Day?  13:40 Dana Foote shares her corporate journey from a young auditor diagnosed with MS to National Managing Partner for Audit & Assurance Operations at KPMG US   15:40 Share this episode  33:20 Have you downloaded the RealTalk MS app?  33:36 Next week  34:21 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/476 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com DOWNLOAD: The RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share REGISTER: ECTRIMS Patient Community Day 2026 https://ectrimspatientcommunity.eu RealTalk MS Episode 461: A New Disease-Modifying Therapy Has Been Submitted for FDA Approval with Dr. Jiwon Oh https://realtalkms.com/461 STUDY: Physiotherapy and Confirmed Disability Improvement in People with Multiple Sclerosis https://msard-journal.com/article/S2211-0348(26)00949-1/fulltext JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 476 Guest: Dana Foote Privacy Policy
New Tools and Strategies for Managing MS-Related Cognitive Changes with Dr. Elizabeth Gromisch
2026/10/05
Whether it's walking into a room and blanking on why you're there, struggling to pull up a word that's right on the tip of your tongue, or losing track of daily tasks, cognitive fatigue and brain fog can turn simple routines into exhausting hurdles. What makes cognitive changes particularly challenging is their invisibility. They don't show up on a routine check-in like mobility issues do. Family members might misread them as distraction. Employers might see them as disengagement. And all too often, clinicians don't have immediate, actionable tools to offer beyond standard advice. This week, we're talking with Dr. Elizabeth Gromisch, a research neuropsychologist at the Mandell Center for Comprehensive Multiple Sclerosis Care and Neuroscience Research at Mount Sinai Rehabilitation Hospital in Hartford, Connecticut. Dr. Gromisch's work focuses on moving beyond the diagnostic label to give people real, evidence-based compensatory tools. We're discussing the science of prospective memory—remembering to perform planned actions in the future—and exploring how smart digital tools, strategic daily systems, and patient empowerment can help you take control and maintain your independence. We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  New tools and strategies for managing and even improving MS-related cognitive changes  :22 We're less than 3 weeks away from MS Toronto 2026 Patient Community Day! Have you registered yet?  1:23 Dr. Elizabeth Gromisch shares a preview of new digital tools to measure and manage MS-related cogntive changes   2:19 Share this episode  28:39 Download the RealTalk MS app  28:58 Next week  29:42 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/475 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com REGISTER: ECTRIMS Patient Community Day 2026 https://ectrimspatientcommunity.eu DOWNLOAD: The New RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 475 Guest: Dr. Elizabeth Gromisch Privacy Policy
Episode 474: The House That MS Built with Sarah Timmerman
2026/09/28
Most people don't think about home accessibility until mobility changes force the conversation. But what if you decide to take control of the unknown and design your living space for whatever the future might bring? My guest, Sarah Timmerman, explains how she took total control of her future by designing and building what she calls The House That MS Built—a home engineered from the foundation up to future-proof her independence through smart, universal design and relentless self-advocacy.  We'll also tell you about a research team that identified 4 biomarkers that, together, can help a neurologist understand whether a stem cell therapy is working for their patient weeks before that patient returns to the clinic. We're sharing results of a trial that answered the question, "Can diet actually change what's happening at the cellular level inside the brain?" You'll want to hear these results! And we'll tell you about a research team that has developed a derivative of an HIV medication that restored mobility and vision to mice with the mouse version of MS.  We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  The House that MS Built  :22 Have you downloaded the new RealTalk MS app for your iOS or Android device?   1:16 Researchers at Tisch Multiple Sclerosis Research Center of New York identify 4 biomarkers that can help physicians track the response to stem cell therapy in people living with progressive MS   2:01 New research identifies how gut health can lead to nerve cell damage in MS   4:49 Repurposed HIV medication restores lost function in the mouse model of MS  8:48 Sarah Timmerman shares her story and explains how relentless self-advocacy became the foundation for the House that MS Built  12:55 Share this episode  24:09 Next week  24:29 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/474 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com DOWNLOAD: The RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share REGISTER: ECTRIMS Patient Community Day 2026 https://ectrimspatientcommunity.eu STUDY: Effect of Intrathecal Injection of Mesenchymal Stem Cell-Neural Progenitors on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis https://pmc.ncbi.nlm.nih.gov/articles/PMC13585449 STUDY: High-Fat Diet Promotes T-Cell Mediated Synaptic Dysfunction in Multiple Sclerosis https://link.springer.com/article/10.1186/s12974-026-04049-x STUDY: The Nucleoside Analog Kamuvudine-9 Shows Protective and Therapeutic Efficacy in a Mouse Model of Multiple Sclerosis https://science.org/doi/10.1126/scitranslmed.aei2870 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 474 Guest: Sarah Timmerman Privacy Policy
Episode 473: The National MS Society -- A CEO Briefing with Dr. Tim Coetzee
2026/09/21
RealTalk MS is celebrating our ninth anniversary, and we're marking the milestone with a special guest! Dr. Tim Coetzee, President and CEO of the National MS Society, returns to the show for a candid, forward-looking conversation about why today represents one of the most promising moments for advancing MS research and transforming clinical care. We're taking a hard look at the game-changers on the horizon: what it will take to shorten the diagnostic journey from years down to mere hours, why it's time to retire outdated disease labels in favor of true precision medicine, and the surprising science behind testing GLP-1s for neuroprotection. From unlocking massive clinical data sets to fighting for research dollars on Capitol Hill, Tim pulls back the curtain on the Society's strategic plan to end MS once and for all. Pop in your earbuds and join us in celebrating nine years of community and conversation! We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  Dr. Tim Coetzee briefs us on the National MS Society's strategic priorities and shares his vision of the future of MS care  :18 Download the new RealTalk MS app for your iOS and Android smartphone and tablet  1:56 We gave the RealTalk MS website a glow-up!   2:37 Check your congressional representative's grade in the Congressional Healthcare Access Report Card  3:07 Dr. Tim Coetzee discusses the MS Society's strategic priorities and shares his vision of the future of MS care  3:46 Share this episode  37:04 Next week  37:24 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/473 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com REGISTER: ECTRIMS Patient Community Day 2026 https://ectrimspatientcommunity.eu DOWNLOAD: The New RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 473 Guest: Dr. Tim Coetzee Privacy Policy
ECTRIMS-ACTRIMS Patient Community Day Preview with Brett Drummond and Dr. Jennifer Graves
2026/09/14
We are less than 40 days away from MSToronto2026—the joint ECTRIMS/ACTRIMS Scientific Congress. While the congress brings together the world's leading MS researchers and clinicians, Patient Community Day —in person and online—is designed specifically for people affected by multiple sclerosis. This week, Dr. Jennifer Graves and Brett Drummond join me to preview what to expect from Patient Community Day 2026. With less than 50 days until the midterm elections in the United States, the National MS Society is hosting a webinar you can't afford to miss, titled MS Advocacy in Action: What the 2026 Elections Could Mean for Healthcare Policy and Access to Care. We'll tell you how to register (And we'll remind you why you should!). A 22-country survey of over 17,000 people with MS revealed that the invisible symptoms of MS remain critically unaddressed. We're sharing the details of this landmark survey. We're sharing early trial results of a precision red blood cell therapy designed to halt myelin attacks without shutting down the immune system. We'll tell you about the German research team that's repurposing a common, low-cost medication into a skin patch designed to jumpstart natural remyelination. And we'll share a study showing how simple, short voice recordings can predict long-term cognitive changes and brain volume loss in people living with MS. We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  A preview of Patient Community Day 2026  :22 The National MS Society is hosting a webinar you shouldn't miss   1:32 Results of a landmark survey reveal critical unmet needs among people living with MS   5:27 A new approach to preventing MS inflammatory attacks while keeping the rest of the immune system intact   8:27 Could a skin patch successfully promote myelin repair?  11:42 Can analyzing regular speech predict future brain atrophy in people with MS?  14:34 Dr. Jennifer Graves and Brett Drummond give us a preview of Patient Community Day 2026  18:53 Share this episode  33:01 Next week  33:20 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/472 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com REGISTER: ECTRIMS Patient Community Day 2026 https://ectrimspatientcommunity.eu WEBINAR: Advocacy In Action: What the 2026 Elections Could Mean for Healthcare Policy and Access to Care https://nmss.quorum.us/event/37051 STUDY: Impact of Multiple Sclerosis Symptoms Survey: Patient-Reported Data on the Prevalence, Burden, and Management of Multiple Sclerosis Symptoms in Europe https://journals.sagepub.com/doi/10.1177/13524585261480514 STUDY: Treatment of Multiple Sclerosis with Peptide-Coupled Red Blood Cells Induces Antigen-Specific T Regulatory Cells https://pnas.org/doi/abs/10.1073/pnas.2614908123 STUDY: Automated Speech Analysis Reveals Progressive Linguistic Changes Associated With Subsequent Gray Matter Loss in Multiple Sclerosis https://journals.sagepub.com/doi/full/10.1177/13524585261477213 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 472 Guest: Brett Drummond and Dr. Jennifer Graves Privacy Policy
Episode 471: Navigating an MS Relapse with Dr. F. Gabriela Karolidis
2026/09/07
Relapses make life with MS unpredictable. Understanding what they are, why they happen, and how best to manage them can make a relapse less scary and easier to navigate.   This week, Dr. Gabriela Karolidis, a board-certified neurologist and neuroimmunologist at Thomas Jefferson University, joins us for a deep dive into MS relapses. The MS International Federation has just updated the Atlas of MS, showing more than 3 million people living with MS worldwide. We're sharing the details behind the new numbers. We'll also share a study showing how wearable activity trackers add a dimension of real-world data that provides a more complete picture of an individual's mobility throughout the day. We'll tell you about research on Vitamin D supplements that fails to determine whether they are beneficial for people living with MS. We're sharing study results showing that social and socioeconomic factors clearly affect cognitive function among people living with MS.  We're also sharing results from a nationwide study in Denmark that focused on whether high-efficacy DMTs affect progression independent of relapse activity (PIRA). And we'll tell you about a fall prevention study that you may be eligible to participate in (compensation provided!). We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Navigating a relapse  :22 Global MS prevalence surpasses 3 million   :57 A study shows that wearable activity trackers help create a more complete picture of an individual's mobility   6:38 Researchers attempt to determine whether Vitamin D supplements help people living with MS   10:14 A study provides evidence that social and socioeconomic factors impact cognitive function in people living with MS  13:58 A nationwide study in Denmark focuses on whether high-efficacy disease-modifying therapies have an impact on progression independent of relapse activity (PIRA)  17:20 You may be eligible to participate in a fall prevention study (compensation is provided)  21:11 Dr. F. Gabriela Karolidis takes us on a deep dive into MS relapses  22:58 Share this episode  37:52 Next week  38:12 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/471 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Global Prevalence of Multiple Sclerosis Surpasses 3 Million: 2024 Update of the Multiple Sclerosis International Federation Atlas of MS https://journals.sagepub.com/doi/10.1177/13524585261479954 RESOURCE: Multiple Sclerosis International Federation Atlas of MS https://msif.org/atlas STUDY: Diurnal Step Count Patterns in Progressive Multiple Sclerosis https://journals.sagepub.com/doi/10.1177/13524585261475910 STUDY: Vitamin D Supplementation and Its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review https://onlinelibrary.wiley.com/doi/10.1002/brb3.71692 STUDY: Social and Socioeconomic Factors and Cognitive Outcomes in Multiple Sclerosis https://sciencedirect.com/science/article/pii/S221103482600475X STUDY: Effectiveness of Escalation Versus Early High-Efficacy Therapies on Progression Independent of Relapse Activity In Multiple Sclerosis: A Danish Nationwide Study https://neurologyopen.bmj.com/content/8/2/e001690 PARTICIPATE: University of Illinois Disability, Participation, and Quality of Life Research Laboratory Fall Prevention Study Email: [email protected] REGISTER: ECTRIMS Patient Community Day https://ectrimspatientcommunity.eu JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 471 Guest: Dr. Gabriela Karolidis Privacy Policy
42 Marathons in 42 Days with Benji Wilkins
2026/08/31
Wise men and women remind us that life is a marathon, and not a sprint. Joining us this week is Benji Wilkins. Benji is a magician in the U.K., and for 42 days this summer, his life was quite literally a marathon. In the process, Benji raised money to help his mom, who lives with MS, and he raised awareness of MS across the U.K. and around the world.   We're also sharing results of a study that focused on gait training using a powered exoskeleton for people living with MS. We'll tell you how you can participate in the MOMENT-MS study and help researchers develop a smartphone app that takes a novel approach to managing MS-related pain. And we're reminding you to register for ECTRIMS Patient Community Day. It's your opportunity to participate in the largest MS research conference in the world! We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Running a marathon a day (when you're not a runner) for MS  :22 Cleveland Clinic researchers look at gait training using a powered exoskeleton for people with MS  1:02 University of Washington researchers are developing an app to manage MS pain using mindfulness-based cognitive therapy. And you can help them!   6:53 Sign up to participate in the largest MS research conference in the world   5:27 Benji Wilkins describes what it's like to run 42 marathons in 42 days on behalf of his mom, who lives with MS  6:53  Share this episode  29:01 Next week  29:20 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/470 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Feasibility and Outcomes of Gait Training With a Powered Exoskeleton in Individuals With Multiple Sclerosis https://pubmed.ncbi.nlm.nih.gov/40465831 SUPPORT: Marathons For Mum Web: https://marathonsformum.com Instagram: https://instagram.com/benjitwilkins PARTICIPATE: MOMENT-MS Study Web:   https://uwmsrehabwell.org/moment-ms Email: [email protected] Video: https://www.youtube.com/watch?v=Z6TA5-9dy7s REGISTER: ECTRIMS Patient Community Day https://ectrimspatientcommunity.eu JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 470 Guest: Benji Wilkins Privacy Policy
Episode 469: Maintaining and Even Improving Cognitive Function If You're Living with MS with Dr. Anna Kratz
2026/08/24
Cognitive changes in MS—fluctuations in processing speed, memory, and executive function—can significantly impact daily life, yet they're often misunderstood or overlooked in routine clinical exams. This week, we are joined by Dr. Anna Kratz, clinical psychologist and Professor in the Department of Physical Medicine and Rehabilitation at the University of Michigan, to discuss actionable, evidence-based ways to navigate cognitive challenges.  Dr. Kratz breaks down the latest findings from the CogDetect-MS study, exploring how daily symptom fluctuations, complex medication regimens, and common substances like caffeine and cannabis influence brain fog. She also shares practical compensatory workarounds and introduces a no-cost digital self-management resource, My MSToolKit. We'll also explain the new framework for describing MS that's been proposed by the International Advisory Committee on Clinical Trials in Multiple Sclerosis. We're sharing study results that reveal why detecting even a single silent lesion on an MRI should trigger an immediate conversation about stepping up to high-efficacy therapy. And we'll tell you about 2 advanced MRI markers that can predict future cognitive decline — even in the absence of any relapses or new lesions on MRI. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Maintaining and improving cognitive function  :22 The International Advisory Committee on Clinical Trials in Multiple Sclerosis calls for updating the way MS is described   1:12 A study provides evidence for switching your DMT when there's even a single silent lesion on your MRI   6:53 Scientists identify two MRI markers that can predict future cognitive decline in early relapsing-remitting MS   10:53 Dr. Anna Kratz discusses maintaining and improving cognitive function  15:33  Share this episode  42:13 Next week  42:33 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/469 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com PAPER: Towards a Biologically Informed Description of Multiple Sclerosis Disease Course -- A Roadmap for Transition https://rdcu.be/fxBw1 STUDY: Treatment Escalation After Clinically Silent MRI Lesions in Relapsing-Remitting Multiple Sclerosis https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awag252/8741305 STUDY: Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple Sclerosis https://onlinelibrary.wiley.com/doi/10.1002/acn3.70448 REGISTER: ECTRIMS Patient Community Day https://ectrimspatientcommunity.eu JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 469 Guest: Dr. Anna Kratz Privacy Policy
Episode 468: You've Been Given a 15% Chance of Living and Your Spouse Gets Diagnosed with MS with Kathleen Silva
2026/08/17
Imagine your spouse or significant other has been diagnosed with MS...shortly after you were diagnosed with stage IV colon cancer, and given just a 15% chance of survival. All of a sudden, the roles of patient and care partner are up for grabs -- and they change with almost daily frequency.  That's exactly the scenario my guest, Kathleen Silva, faced. Kathleen is joining me to discuss how she and her husband, Rick, survived and thrived amid that frightening chaos. (Spoiler alert -- no one died!)  We'll also tell you about an investigational drug that's the first to promise neuroprotection during an MS relapse. We're sharing study results that show people with MS who meet the medical criteria aren't jumping on the GLP-1 bandwagon. We'll provide compelling evidence for anyone with MS to quit smoking.  And we're breaking down the results of a study that analyzed mortality rates in cases where MS was listed as the underlying cause of death. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: When the roles of patient and care partner get turned upside down and inside out  :22 The FDA green lights clinical trials for an investigational drug that promises neuroprotection during an MS relapse   1:08 People living with MS who meet the medical criteria aren't jumping on the GLP-1 bandwagon   5:43 Study results provide startling evidence for quitting smoking if you're living with MS   8:34 In spite of highly effective DMTs, mortality rates for deaths in which MS is listed as the underlying cause are increasing  14:05 Kathleen Silva takes us through the harrowing time in her life when her husband, Rick, was diagnosed with MS shortly after she had been diagnosed with Stage 4 colon cancer and given just a 15% chance of surviving   19:23  Share this episode  35:12 Next week  36:31 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/468 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Use of Semaglutide and Tirzepatide Among People with Multiple Sclerosis https://journals.sagepub.com/doi/10.1177/13524585261442033 STUDY: Impact of Tobacco and Alcohol Consumption on Disease Progression and MRI In People With Multiple Sclerosis: Results of the Prospective Cohort Study NationMS https://journals.sagepub.com/doi/10.1177/17562864261464304 STUDY: Racial and Ethnic Trends and Comorbidity Patterns in Multiple Sclerosis Mortality https://www.neurology.org/doi/10.1212/WN9.0000000000000148 REGISTER: ECTRIMS Patient Community Day https://ectrimspatientcommunity.eu JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 468 Guest: Kathleen Silva Privacy Policy
Making Shared Decision-Making Work with Dr. Aliza Ben-Zacharia and Linda Lachman
2026/08/10
If you Google the term "shared decision making", you'll find it defined as a collaborative process where patients and clinicians work together to select tests, treatments, and care plans based on clinical evidence and the patient's personal values and goals. But shared decision-making isn't an automatic happy pill. It takes work, it takes discipline, and it takes a clear understanding of both the patient's and the clinician's roles. This week, Dr. Aliza Ben-Zacharia and Linda Lachman join me to share how shared decision-making has worked for them over the course of their longtime doctor-patient relationship, and how it can work for you. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're taking a deep dive into shared decision-making  :22 Dr. Aliza Ben-Zacharia and Linda Lachman discuss how they have made shared decision-making work, and what to do if it isn't working for you and your neurologist  2:39 Share this episode  32:05 Next week  32:25 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/467 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 467 Guests: Dr. Aliza Ben-Zacharia and Linda Lachman Privacy Policy

Podcast reviews

Read RealTalk MS podcast reviews


4.7 out of 5
153 reviews
★★★★★
Zia Nova 2026/03/24
Because Science
This podcast makes MS research approachable without losing the depth that actually matters. I value how the host, Jon Strum, walks through the latest ...
★★★★★
Written Art 2025/11/02
Use your voice
Excellent podcast 10/28/25. US Const protects MS pts. Current admin disallows DOJ to prosecute. In this situation, ride your State & US Reps hard. Spe...
★★★★★
Bubblesforver123 2024/06/10
Helpful and inspiring
Wow- I can’t believe I just found out about this podcast! It is so informative and keeps me educated on so many things. The resources provided are sup...
★★★★★
AIRiel Kara 2021/08/26
Thank you
I’m grateful this podcast exists, it’s the main way that I educate myself about MS. John is awesome and makes sure that all the details are communicat...
★★★★☆
Farmer188 2021/07/17
PBA please
Real Talk, please- please- please, address PBA. If I have missed it, please reply. I am on a mission.
★★★★★
DefJuan 2021/05/12
Outstanding resource
As someone with a family member living with MS, trying to understand all of the facets of the condition can be daunting. This podcast goes above and b...
★★★★★
Xrodeoqueen 2021/05/04
So much Real information!!
This podcast is based on real science, not the latest fad or unproven treatments/diets.
★★★★★
MD76ax 2021/04/27
Most Informative MS Podcast Available
John is an incredible podcast host aggregating all of the topical and relevant MS-related news and discussing it simply and succinctly so any listener...
★★★★★
Swarled 2021/03/05
Fantastic and Informative
I got diagnosed with MS on February 3 and this was the first podcast that I turned to for resources on how to handle everything that was happening to ...
★★★★★
skdfir 2021/02/26
Very informative
The host asks great questions of his top-notch guests and the topics are wide ranging. An invaluable resource to those with MS and their caregivers.
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on RealTalk MS relevant audience podcasts


What do you want to promote?